Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yukie Terasaki
Observed name:
Y Terasaki
Institution:
Tokyo Metropolitan Komagome Hospital
Observed institutions:
Gunma University,
Tokyo Metropolitan Komagome Hospital,
Gunma Saiseikai Maebashi Hospital,
National Hospital Organization,
Gunma University Hospital,
National Hospital Organization Shibukawa Medical Center
show all 6
OpenAlex ID:
A5073790089
Improved non-relapse mortality in allogeneic hematopoietic stem cell transplantation: a long-standing multidisciplinary pursuit at a single center
2025
·
Shuhei Kurosawa
, Kairi Kojo
, et al.
·
Bone Marrow Transplantation
·
6
Real‐World Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients
2025
·
Yasutaka Masuda
, Takashi Toya
, et al.
·
Transplant Infectious Disease
·
4
Improving gastrointestinal quality of life: romidepsin to tucidinostat in a case of angioimmunoblastic T cell lymphoma
2024
·
Atsushi Isoda
, Yukie Terasaki
, et al.
·
BMJ Case Reports
·
3
PDF
Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain
2024
·
Hirono Iriuchishima
, Akio Saito
, et al.
·
International Journal of Hematology
·
2
Slowly progressing acute lymphoblastic leukemia with prolonged leukopenia
2023
·
Manato Sugisaki
, Kenji Imamura
, et al.
·
SAGE Open Medical Case Reports
·
2
PDF
[Gross spreading multiple extramedullary plasmacytomas to the skin in the terminal stage of multiple myeloma].
2001
·
M Kanno
, S Nakamura
, et al.
·
PubMed
·
2
Risk Factors for Central Nervous System (CNS) Relapse after Autologous Stem Cell Transplant (ASCT) in Diffuse Large B-Cell Lymphoma (DLBCL)
2019
·
Yukie Terasaki
, Hiroaki Shimizu
, et al.
·
Blood
·
1
Clinical impact of infused CD3-positive cell dose in unrelated peripheral blood stem cell transplantation
2026
·
Yasutaka Sadaga
, Shuhei Kurosawa
, et al.
·
International Journal of Hematology
[Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis].
2026
·
Kairi Kojo
, Yuho Najima
, et al.
·
PubMed
TP53, EZH2, or RUNX1 mutations predict poor outcomes in ELN 2022 adverse risk group of adult AML patients undergoing allo-HSCT
2025
·
Kairi Kojo
, Hiroaki Shimizu
, et al.
·
Blood
PDF
Drug‐induced liver injury due to granulocyte colony‐stimulating factor in a healthy donor for allogeneic peripheral blood stem cell transplantation
2025
·
Kana Kato
, Shuhei Kurosawa
, et al.
·
Vox Sanguinis
Triple-hit TdT-positive high-grade B-cell lymphoma mimicking B-lymphoblastic lymphoma and exhibiting immunophenotypic change at relapse
2025
·
Akio Saito
, Atsushi Isoda
, et al.
·
Journal of the Japan Society of the Reticuloendothelial System
PDF
Revealing cyclic thrombocytopenia: The role of periodogram analysis and the impact of thrombopoietin receptor agonist therapy
2024
·
Atsushi Isoda
, Hiroaki Kurashina
, et al.
·
International Journal of Laboratory Hematology
Cyanamide Induced Aplastic Anemia
2018
·
Yohei Osaki
, Yukie Terasaki
, et al.
·
The Kitakanto Medical Journal
PDF
Show more works
View as search
Works count:
14
Citation count:
20
H-index:
3
I10-index:
Year
Topic
Type